Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

172.34
Delayed Data
As of Jan 22
 +5.59 / +3.35%
Today’s Change
84.97
Today|||52-Week Range
175.41
+32.60%
Year-to-Date
3 Lesser-Known Biotech Stocks that are Surging
Jan 20 / StockNews.com - Paid Partner Content
Vir Biotech, Glaxo to Begin Study on Second COVID-19 Therapy
Jan 13 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close166.75
Today’s open166.37
Day’s range164.03 - 173.30
Volume33,632
Average volume (3 months)581,049
Market cap$20.0B
Data as of 3:59pm ET, 01/22/2021

Growth & Valuation

Earnings growth (last year)-7.13%
Earnings growth (this year)+11.46%
Earnings growth (next 5 years)+29.35%
Revenue growth (last year)+193.36%
P/E ratioNM
Price/Sales57.26
Price/Book13.42

Competitors

 Today’s
change
Today’s
% change
CTLTCatalent Inc-1.42-1.20%
INCYIncyte Corp+3.98+4.24%
VTRSViatris Inc+0.12+0.69%
HZNPHorizon Therapeutics...+0.29+0.37%
Data as of 4:00pm ET, 01/22/2021

Financials

Next reporting dateFebruary 11, 2021
EPS forecast (this quarter)-$1.76
Annual revenue (last year)$219.8M
Annual profit (last year)-$886.1M
Net profit margin-403.24%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Cambridge, Massachusetts

Forecasts